Urolithiasis, a condition affecting approximately 10% of the global population, is primarily treated with Shock Wave Lithotripsy (SWL) and endoscopic methods. However, SWL's high-pressure pulses can cause tissue injury, often necessitates some level of anaesthesia, and may require repeated sessions or ancillary treatment to achieve stone free status.
The SMART Stone Multidisciplinary Team (MDT) recommendations aim to provide guidance on the role of the MDT in the early identification, referral and assessment of adult high-risk recurrent kidney stone formers to advance patient care.
Urolithiasis is one of the most common diseases worldwide, characterized by high morbidity and significant treatment-related costs, with a rising prevalence of up to 20%. The relapse rate within the first 10 years after initial treatment is estimated to be about 60%.
The European Association of Urology urolithiasis guidelines provide evidence-based recommendations for the diagnosis and treatment of urinary stone disease. Given the complexity and variability of stone formation, individualised patient management is emphasised.
Nephrolithiasis (kidney stone disease) continues to pose a significant global health challenge, affecting millions of individuals and placing substantial economic pressures on healthcare systems. Traditional diagnostic methods-such as computed tomography (CT), ultrasound, and basic urinalysis-are often limited by issues including radiation exposure, lower sensitivity in detecting small stones, operator dependency, and the inability to provide real-time analysis.
This study aimed to ascertain the relevance of the Guy's stone score in the evaluation and outcome of percutaneous nephrolithotomy (PCNL).
This 2-year hospital-based, prospective clinical study enrolled 100 patients who were indicated for PCNL.
With advancements in laser technology and urological techniques, flexible ureterorenoscopy has emerged as a vital surgical approach for managing stone disease. Various techniques can be employed to customize endourological stone treatments.
This study aims to investigate the comprehensive association between healthy dietary patterns, biological aging, and kidney stones in a large population-based cohort.
We analyzed data from 6 cycles of NHANES surveys from 2007 to 2018 and included a total of 26,755 participants.
Obesity is a primary risk factor associated with kidney stones (KS), with evidence suggesting that increasing BMI, obesity, and metabolic syndrome over the past three decades correlate with an elevated risk of hyperoxaluria.
The risk of chronic kidney disease (CKD) and nephrolithiasis increases with higher levels of oxalate excretion in 24-h urine, warranting monitoring in specific populations, especially after malabsorptive bariatric surgery.
